98%
921
2 minutes
20
Treatment outcomes for individuals with substance use disorders (SUDs) are variable and more individualized approaches may be needed. Cross-validated, machine-learning methods are well-suited for probing neural mechanisms of treatment outcomes. Our prior work applied one such approach, connectome-based predictive modeling (CPM), to identify dissociable and substance-specific neural networks of cocaine and opioid abstinence. In Study 1, we aimed to replicate and extend prior work by testing the predictive ability of the cocaine network in an independent sample of 43 participants from a trial of cognitive-behavioral therapy for SUD, and evaluating its ability to predict cannabis abstinence. In Study 2, CPM was applied to identify an independent cannabis abstinence network. Additional participants were identified for a combined sample of 33 with cannabis-use disorder. Participants underwent fMRI scanning before and after treatment. Additional samples of 53 individuals with co-occurring cocaine and opioid-use disorders and 38 comparison subjects were used to assess substance specificity and network strength relative to participants without SUDs. Results demonstrated a second external replication of the cocaine network predicting future cocaine abstinence, however it did not generalize to cannabis abstinence. An independent CPM identified a novel cannabis abstinence network, which was (i) anatomically distinct from the cocaine network, (ii) specific for predicting cannabis abstinence, and for which (iii) network strength was significantly stronger in treatment responders relative to control particpants. Results provide further evidence for substance specificity of neural predictors of abstinence and provide insight into neural mechanisms of successful cannabis treatment, thereby identifying novel treatment targets. Clinical trials registation: "Computer-based training in cognitive-behavioral therapy web-based (Man VS Machine)", registration number: NCT01442597 . "Maximizing the Efficacy of Cognitive Behavior Therapy and Contingency Management", registration number: NCT00350649 . "Computer-Based Training in Cognitive Behavior Therapy (CBT4CBT)", registration number: NCT01406899 .
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10713861 | PMC |
http://dx.doi.org/10.1038/s41380-023-02120-0 | DOI Listing |
Psychopharmacology (Berl)
September 2025
Center for Medicinal Cannabis Research, Department of Psychiatry, University of California San Diego, San Diego, CA, USA.
Rationale: Between periods of use, chronic cannabis consumers may display residual effects on selective cognitive functions, particularly memory and attention. Whether there are comparable deficits in real-world behaviors, such as driving, has not been thoroughly examined.
Objectives: The current study explored the association between driving simulator performance, cannabis use history, and demographic factors after ≥ 48 h of abstinence.
Front Psychol
August 2025
Department of Health Psychology and Center for Applied Psychology, Miguel Hernández University, Elche, Spain.
Introduction: The use of alcohol is a prevalent phenomenon among adolescents. Several brief intervention strategies have been developed to prevent the progression of alcohol use to high-risk levels. The consumer profile, including whether they have consumed one or more substances, may be a key variable in analyzing the effectiveness of interventions.
View Article and Find Full Text PDFNervenarzt
September 2025
Institut für Public Health und Pflegeforschung, Abteilung für Gesundheit und Gesellschaft, Arbeitseinheit Glücksspielforschung, Universität Bremen, Bremen, Deutschland.
Aim: From a public health perspective, the provision of information on low-risk consumption is highly relevant for behavior with addictive potential and negative health, psychological or social consequences. This article provides an overview of the effectiveness and benefits of such recommendations for alcohol, cannabis, gambling and gaming.
Methods: An overview based on a narrative review.
Br J Pharmacol
August 2025
Harvard Medical School, McLean Hospital, Belmont, Massachusetts, USA.
Background And Purpose: Legalisation of Cannabis use has led to considerable increases in the availability and potency of Cannabis products, as well as evolving patterns in methods of their consumption. Adolescent Cannabis use has increased, which can impair cognitive function during this critical developmental stage. The persistence of such effects into adulthood, however, is unclear.
View Article and Find Full Text PDFPsychoneuroendocrinology
August 2025
Department of Family Medicine and Biobehavioral Health, University of Minnesota Medical School, Duluth, MN 55812-2487, USA. Electronic address:
Nicotine and cannabis are commonly used substances that impact overall health. With increasing reports of nicotine and cannabis co-use, additional challenges arise for programs aimed at addressing cessation. This study examined the independent and additive effects of substance use on adrenocortical and psychological measures in nicotine users, cannabis users, co-users and non-users.
View Article and Find Full Text PDF